DCF — SOUTHERN REGIONAL MEDICAL CORP
Enterprise Value: $-86.0M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-86.0M
Enterprise Value
$-28.8M
PV of Cash Flows
$-57.3M
PV of Terminal Value
$-92.2M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $100.2M | $-4.5M | -4.0% | $-8.8M | $-8.0M |
| Year 2 | $103.2M | $-3.6M | -3.0% | $-8.0M | $-6.6M |
| Year 3 | $106.3M | $-2.7M | -2.0% | $-7.2M | $-5.4M |
| Year 4 | $109.5M | $-2.2M | -2.0% | $-6.8M | $-4.7M |
| Year 5 | $112.8M | $-2.0M | -2.0% | $-6.7M | $-4.2M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-86.0M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$97.3M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.04999999691603428
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5